2m 2m 2m 2m 2m 2m 2m
Clvr Hlth Inv-A (CLOV)
NASDAQ
$5.06-$0.08 (-1.65%)
Price as of Jun 23, 2026 7:58 PM EDT- $2.2BMarket Cap
- 81.63%1-Year Change
- Healthcare PlansIndustry
Clvr Hlth Inv-A (CLOV)
$5.06-$0.08 (-1.65%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.9B +40.34% | 1.4B -32.58% | 2.0B -41.50% | 3.5B +136.19% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 1.9B +40.34% | 1.4B +432.83% | 257.3M +1,031.88% | 22.7M +128.71% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | 0 N/A | 0 -100.00% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 1.7M +26.67% | 1.3M -46.95% | 2.5M +111.37% | 1.2M -4.74% | |
Total Operating Expenses | 2.0B +41.85% | 1.4B -36.81% | 2.2B -41.72% | 3.8B +82.44% | |
Operating Profit | -85.5M +86.95% | -45.7M -78.06% | -208.5M -43.78% | -370.9M -41.77% | |
Interest Income | 0 +100.00% | -467,000 -90.12% | -4.7M -151.27% | 9.2M N/A | |
Interest Expense | N/A N/A | N/A N/A | -7,000 -99.47% | -1.3M -58.72% | |
Interest Income and Expense and Net | 0 +100.00% | -467,000 -90.13% | -4.7M -160.03% | 7.9M +344.16% | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | 7,000 -99.47% | 1.3M -58.72% | |
Income before Taxes | -85.5M +84.91% | -46.3M -77.81% | -208.5M -43.78% | -370.9M -41.77% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | 0 N/A | 0 -100.00% | 4.2M N/A | N/A N/A | |
Net Income | -85.5M +98.91% | -43.0M -79.84% | -213.4M -37.03% | -338.8M -42.35% | |
Net Income from Continuing Operations Applicable to Common | -85.5M +84.91% | -46.3M -78.32% | -213.4M -37.03% | -338.8M -42.35% | |
Basic EPS and Net Income | N/A N/A | N/A N/A | -0.44 -38.03% | -0.71 -50.00% | |
Diluted EPS and Net Income | N/A N/A | N/A N/A | -0.44 -38.03% | -0.71 -50.00% | |
Basic Weighted Average Shares | 512.0M +4.48% | 490.0M +1.63% | 482.2M +1.25% | 476.2M +15.34% | |
Diluted Weighted Average Shares | 512.0M +4.48% | 490.0M +1.63% | 482.2M +1.25% | 476.2M +15.34% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 78.3M -59.75% | 194.5M +58.34% | 122.9M +18.38% | 103.8M -65.40% | |
Short-Term Investments | 23.1M -14.32% | 27.0M -73.19% | 100.7M -46.86% | 189.5M +796.78% | |
Cash and Cash Equivalents and Short-Term Investments | 101.4M -54.22% | 221.5M -0.91% | 223.6M -23.77% | 293.3M -8.66% | |
Total Current Assets | 307.9M -10.28% | 343.1M -19.83% | 428.0M -31.52% | 625.0M -16.95% | |
Accumulated Depreciation | 7.6M +28.51% | 5.9M +29.04% | 4.6M +98.31% | 2.3M -0.04% | |
Property and Plant and Equipment and Net | 6.4M +20.31% | 5.3M +4.43% | 5.1M -11.66% | 5.8M +151.55% | |
Total Long-Term Assets | 24.1M +81.90% | 13.3M +29.41% | 10.2M -34.88% | 15.7M +50.83% | |
Total Assets | 541.0M -6.84% | 580.7M +1.76% | 570.7M -29.43% | 808.6M -14.95% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 1.6M -32.50% | |
Total Current Liabilities | 208.8M -2.20% | 213.5M -18.23% | 261.1M -40.74% | 440.7M +18.26% | |
Total Long-Term Debt | 40.4M 0.00% | 40.4M 0.00% | 40.4M N/A | 0 -100.00% | |
Total Long-Term Liabilities | 23.5M -9.96% | 26.1M +29.35% | 20.2M +24.52% | 16.2M +14.88% | |
Total Liabilities | 232.3M -3.04% | 239.6M -15.72% | 284.3M -38.32% | 460.9M +12.00% | |
Retained Earnings | -2.3B +3.88% | -2.2B +1.99% | -2.2B +10.44% | -2.0B +20.96% | |
Total Stockholders Equity | 308.7M -9.51% | 341.1M +19.12% | 286.4M -17.64% | 347.7M -35.05% | |
Total Shares Outstanding | 426.7M -69.99% | 1.4B +3.06% | 1.4B +2.87% | 1.3B +42.38% | |
Cash Flow | |||||
Cash from Operating Activities | -66.9M -292.09% | 34.8M +130.07% | -115.9M -43.18% | -203.9M -27.77% | |
Capital Expenditures | 2.0M +31.30% | 1.6M +166.44% | 584,000 -86.93% | 4.5M +517.84% | |
Cash from Investing Activities | 4.1M +621.42% | 565,000 -99.60% | 140.0M +47.18% | 95.1M +121.85% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Cash from Financing Activities | -53.4M +207.49% | -17.4M -48.73% | -33.9M +582.41% | -5.0M -100.54% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -4.44% +33.21% | -3.34% -67.46% | -10.25% -3.89% | -10.67% -75.35% | |
Return on Assets | -15.25% +104.17% | -7.47% -75.85% | -30.94% -19.68% | -38.52% -40.78% | |
Return on Equity | -26.33% +92.08% | -13.71% -79.63% | -67.29% -12.31% | -76.74% -64.72% | |
Revenue Growth | 40.34% +223.83% | -32.58% -21.50% | -41.50% -130.48% | 136.19% N/A | |
Current Ratio | 1.47 -8.26% | 1.61 -1.95% | 1.64 +15.56% | 1.42 -29.77% | |
Cash Ratio | 0.38 -58.84% | 0.91 +93.65% | 0.47 +99.79% | 0.24 -70.75% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.005 -89.18% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.002 -91.88% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow